Aytu BioScience Inc (AYTU NASDAQ) stock market data APIs
$2.2683
0.06(2.6%)
as of October 22, 2025
Try our APIs with
free plan!
Aytu BioScience Inc Financial Data Overview
Price chart is built with
Anychart
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Prev. Close
2.2683
Open
2.3312
High
2.3459
Low
2.2455
52 wk Range
0.95-2.82
Market Cap
22 500 K
Shares Outstanding
9 912 K
Revenue
66 382 K
EPS
-2.93
Beta
0.276
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Aytu BioScience Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Aytu BioScience Inc data using free add-ons & libraries
Get Aytu BioScience Inc Fundamental Data
Aytu BioScience Inc Fundamental data includes:
- Net Revenue: 66 382 K
- EBITDA: 7 914 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-23
- EPS/Forecast: 0.53
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Aytu BioScience Inc News
New
New Strong Sell Stocks for Oct. 13th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Aytu BioPharma AYTU is a healthcare company which focused on commercialization of novel products in the field of urology. Th...
Aytu outlines EXXUA launch targeting $22B MDD market while streamlining ADHD portfolio
Earnings Call Insights: Aytu BioPharma (AYTU) Q4 2025 MANAGEMENT VIEW * CEO Joshua Disbrow highlighted "the strong financial performance during the recent fiscal year and perhaps more importantly,...
Aytu BioPharma GAAP EPS of -$2.93 misses by $2.88, revenue of $15.1M misses by $2.82M
* Aytu BioPharma press release [https://seekingalpha.com/pr/20242010-aytu-biopharma-reports-fiscal-2025-full-year-and-fourth-quarter-operational-and-financial] (NASDAQ:AYTU [https://seekingalpha.com...
Here are the major earnings after the close Tuesday
Major earnings expected after the bell on Tuesday include: * Aytu BioPharma (AYTU [https://seekingalpha.com/symbol/AYTU]) * AAR Corp. (AIR [https://seekingalpha.com/symbol/AIR]) * MillerKnoll (...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
